Codoxo
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|
Revenues | 1.1m | 1.3m | 3.4m | 7.9m |
% growth | - | 14 % | 166 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$340k | Grant | ||
$100k | Seed | ||
N/A | Spinout | ||
$1.5m | Seed | ||
N/A | $480k | Seed | |
$7.0m | Series A | ||
* | $20.0m | Series B | |
Total Funding | AUD45.5m |
Recent News about Codoxo
EditCodoxo specializes in developing AI-driven solutions aimed at helping healthcare companies and agencies identify and address cost-related issues swiftly. Operating within the healthcare sector, Codoxo serves a diverse range of clients including health plans, pharmacy benefit managers (PBMs), and government agencies. The company leverages its patented AI technology to ensure payment integrity and to detect fraud, waste, and abuse that other solutions might miss. Codoxo's business model revolves around offering a suite of products and services such as Prior Authorization Acceleration, Network Integrity Contract Management, and Outsourced Virtual Services. These offerings are designed to improve efficiency, transparency, and insight within healthcare operations. The company generates revenue through subscription-based models and professional services, including data migration and ongoing customer success support. Codoxo's AI solutions are recognized for their speed in detection and deployment, which helps clients contain costs more effectively. The company's mission is to disrupt the status quo in healthcare cost management, making it more affordable and effective through innovative AI technology.
Keywords: AI-driven, healthcare, cost containment, fraud detection, payment integrity, health plans, PBMs, government agencies, subscription-based, professional services.